ArticleCell proliferation2026
Ammonia Accumulation Drives Intervertebral Disc Degeneration by Triggering Ammonia-Induced Cell Death Through Lysosome-Mitochondria Crosstalk.
Article in Cell proliferation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Intervertebral disc degeneration (IVDD) is a major cause of low back pain and is closely associated with metabolic imbalance within the disc microenvironment, yet the underlying mechanisms remain poorly understood. Here, we identify ammonia accumulation as a metabolically relevant stressor that promotes nucleus pulposus cell injury and death and characterise ammonia-induced cell death (AICD) as a non-canonical, metabolite-driven pathological process in IVDD. Through a combination of clinical cohort-based analyses of human samples, multi-omics profiling, in vitro experiments, and in vivo models, we demonstrate that ammonia stress induces AICD characterised by coordinated disruption of organelle homeostasis. Mechanistically, ammonia accumulation initially impairs lysosomal integrity, which subsequently triggers mitochondrial dysfunction and oxidative stress, accompanied by a metabolic shift from oxidative phosphorylation towards glycolysis, ultimately leading to suppressed mitophagy and activation of cell death pathways. Notably, AICD exhibits crosstalk with multiple programmed cell death pathways, highlighting its integration within the broader cell death network. Importantly, modulation of ammonia levels or restoration of organelle homeostasis effectively alleviates NP cell injury and attenuates IVDD progression. Collectively, these findings support AICD as a previously underappreciated, metabolite-driven process contributing to IVDD and highlight the ammonia metabolism-organelle axis as a potential target for future metabolism- and organelle-directed therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.